These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 14243441)

  • 41. Specific antigenicity of tumors and immunological tolerance in the rat induced by Friend, Gross, and Rauscher viruses.
    Kobayashi H; Kuzumaki N; Gotoda E; Takeichi N; Sendo F
    Cancer Res; 1973 Jul; 33(7):1598-603. PubMed ID: 4124486
    [No Abstract]   [Full Text] [Related]  

  • 42. Clonal heterogeneity of anti-AKR/gross leukemia virus cytotoxic T lymphocytes. Evidence for two distinct antigen systems.
    Azuma H; Phillips JD; Green WR
    J Immunol; 1987 Oct; 139(7):2464-73. PubMed ID: 2821116
    [TBL] [Abstract][Full Text] [Related]  

  • 43. AKR mouse leukemic cells in tissue culture. II. Immunologic studies on the AKR 87 cell line.
    Duś D; Harlozińska A; Skriabin A; Richter R
    Arch Immunol Ther Exp (Warsz); 1976; 24(5):727-40. PubMed ID: 187141
    [TBL] [Abstract][Full Text] [Related]  

  • 44. EARLY AND LATE LEUKEMIAS IN RATS AFTER TRANSPLANTATION OF LEUKEMIC CELLS FROM AKR MICE.
    KIRSTEN WH; PLATZ CE
    Cancer Res; 1964 Jul; 24():1056-62. PubMed ID: 14195343
    [No Abstract]   [Full Text] [Related]  

  • 45. Tumour-associated transplantation antigens of neoplasms induced by a naturally occurring murine sarcoma virus (FBJ-MSV).
    Jones DB; Moore M
    Br J Cancer; 1973 Jun; 27(6):415-26. PubMed ID: 4516007
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. I. Isolation of a selectively resistant variant tumor subclone.
    Green WR
    Eur J Immunol; 1983 Nov; 13(11):863-70. PubMed ID: 6196206
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of a rapidly growing AKR lymphoblastic cell line maintaining Gross antigens and viral replication.
    Woods WA; Wivel NA; Massicot JG; Chirigos MA
    Cancer Res; 1970 Aug; 30(8):2147-55. PubMed ID: 4918189
    [No Abstract]   [Full Text] [Related]  

  • 49. CD4-CD8+ T lymphocytes mediate AKR/gross murine leukemia virus nonresponsiveness in moderately aged AKR.H-2b:Fv-1b mice.
    Rich RF; Fujii T; Green WR
    J Immunol; 1992 May; 148(9):2961-7. PubMed ID: 1349325
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiple antigens related to the major envelope glycoprotein of murine leukemia virus expressed on B16 melanoma cells as targets of host immune response.
    Stackpole CW; Demsey A
    Invasion Metastasis; 1984; 4(1):28-46. PubMed ID: 6329988
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characteristics of Gross virus-induced leukemia cell clones. II. Oncornavirus production.
    Marra M; Imagawa DT
    J Natl Cancer Inst; 1976 Nov; 57(5):1133-8. PubMed ID: 1003546
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HISTOCOMPATIBILITY GENES OF MICE. V. FIVE NEW HISTOCOMPATIBILITY LOCI IDENTIFIED BY CONGENIC RESISTANT LINES ON A C57B 10 BACKGROUND.
    SNELL GD; BUNKER HP
    Transplantation; 1965 Mar; 3():235-52. PubMed ID: 14265497
    [No Abstract]   [Full Text] [Related]  

  • 53. Tumor induction by murine sarcoma virus in AKR and C58 mice. Reduction of tumor regression associated with appearance of Gross leukemia virus pseudotypes.
    Chieco-Bianchi L; Colombatti A; Collavo D; Sendo F; Aoki T; Fischinger PJ
    J Exp Med; 1974 Nov; 140(5):1162-79. PubMed ID: 4608945
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heterogenization of normal tissues in oncogenesis. A skeptical review.
    Mariani T; Good RA
    Isr J Med Sci; 1973 Mar; 9(3):380-94. PubMed ID: 4575655
    [No Abstract]   [Full Text] [Related]  

  • 55. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
    Green WR
    J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Variations among sublines of inbred AKR mice.
    Acton RT; Blankenhorn EP; Douglas TC; Owen RD; Hilgers J; Hoffman HA; Boyse EA
    Nat New Biol; 1973 Sep; 245(140):8-10. PubMed ID: 4353891
    [No Abstract]   [Full Text] [Related]  

  • 57. STUDIES OF LEUKEMIA L1210 HOMOGRAFT IN SWISS HA-ICR MICE.
    BRADNER WT; BACHMAN S; PINDELL MH
    Cancer Chemother Rep; 1964 Jul; 39():21-39. PubMed ID: 14201273
    [No Abstract]   [Full Text] [Related]  

  • 58. [Induction of Gross viral leukemia in C57B1-6 adult mice by injection of AkR (K36) cells].
    Ajuria E; Doré M; Doré JF
    Rev Fr Etud Clin Biol; 1969; 14(7):700-2. PubMed ID: 5354664
    [No Abstract]   [Full Text] [Related]  

  • 59. GROWTH AND MORPHOLOGY OF MOUSE LYMPHOMA CELLS IN DIFFUSION CHAMBERS.
    HAYS EF
    Proc Soc Exp Biol Med; 1964 Oct; 117():45-50. PubMed ID: 14219956
    [No Abstract]   [Full Text] [Related]  

  • 60. PATTERNS OF CELLULAR DIFFERENTIATION IN SPONTANEOUS AND TRANSPLANTED LYMPHOMATA IN MICE.
    METCALF D; NAKAMURA K; WIADROWSKI M
    Aust J Exp Biol Med Sci; 1965 Jul; 43():413-20. PubMed ID: 14343502
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.